CL2008001765A1 -
Compounds derived from n- (3-phenyl-benzo [d] isoxazol-6-yl) -2-hydroxy-3,5-diiodo-benzamide; Preparation process; pharmaceutical composition comprising said compound; Preparation process; and use of the compound in the treatment of endo- and ectoparasite infections.
- Google Patents
Compounds derived from n- (3-phenyl-benzo [d] isoxazol-6-yl) -2-hydroxy-3,5-diiodo-benzamide; Preparation process; pharmaceutical composition comprising said compound; Preparation process; and use of the compound in the treatment of endo- and ectoparasite infections.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NvfiledCriticalJanssen Pharmaceutica Nv
Publication of CL2008001765A1publicationCriticalpatent/CL2008001765A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compuestos derivados de benzo[d]isoxazolil benzamida; procedimiento de preparación; composición farmacéutica que comprende a dicho compuesto; procedimiento de preparación; y uso del compuesto en el tratamiento de infecciones por endo- y ectoparásitos.Compounds derived from benzo [d] isoxazolyl benzamide; preparation procedure; pharmaceutical composition comprising said compound; preparation procedure; and use of the compound in the treatment of endo- and ectoparasite infections.
CL2008001765A2007-06-152008-06-13
Compounds derived from n- (3-phenyl-benzo [d] isoxazol-6-yl) -2-hydroxy-3,5-diiodo-benzamide; Preparation process; pharmaceutical composition comprising said compound; Preparation process; and use of the compound in the treatment of endo- and ectoparasite infections.
CL2008001765A1
(en)
Compounds derived from n- (3-phenyl-benzo [d] isoxazol-6-yl) -2-hydroxy-3,5-diiodo-benzamide; Preparation process; pharmaceutical composition comprising said compound; Preparation process; and use of the compound in the treatment of endo- and ectoparasite infections.
Compounds derived from quinoline or benzopyran hiv replication inhibitors; pharmaceutical composition comprising said compounds; and its use in the treatment of a hiv infection
Compounds derived from pyridin-3-yl-oxypyridin-2-yl-amino, alk5 inhibitors; pharmaceutical composition comprising said compound; and use of the compound in the treatment of cancer.
COMPOUNDS DERIVED FROM REPLACED HETEROPENTACICLOS; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER.
COMPOUNDS DERIVED FROM INDOL WITH UNITED RING IN POSITIONS 4,5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND TO TREAT A VIRAL INFECTION.
Compounds derived from n- (pyridin-3-yl) -1,3-thiazole-5-amino-4-carboxamide, pim kinase inhibitors; pharmaceutical composition; and use for the treatment of cancer.
Compounds derived from chromans and naphthalene substituted with a heterocyclic ring; pharmaceutical composition; and its use in the treatment of acute or chronic nociceptive pain or pain, visceral pain, inflammatory and / or central or peripheral neuropathic pain.
COMPOUNDS DERIVED FROM SUBSTITUTED ISOXAZOLINS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND FOR THE TREATMENT OF A DISEASE CAUSED BY AN INCREASE IN THE CELL PROLIFERATION.
COMPOUNDS DERIVED FROM PYRIMIDILCICLOPENTANOS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF AN INFLAMMATORY, HYPERPROLIFERANT, CARDIOVASCULAR, NEURODEGE DISEASE
Compounds derived from thienopyridine, inhibitors of the hiv integrase enzyme; pharmaceutical composition comprising said compounds; and its use to treat an HIV infection.
Compounds derived from pyrazolic heterobicycles, inhibitors of thyroxine kinase protein activity; pharmaceutical composition comprising said compounds; and use of the compounds in the treatment of a hyperproliferative disease.
Nucleotide derived compounds, hepatitis c virus ns5b polymerase inhibitors; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c.
Compounds derived from 2-pyridinecarboxamide, glucosinase activator; pharmaceutical composition; and use of the compound for the treatment of diabetes or obesity.
Compounds derived from n-phenyl-3-thio-4-phenyl-azetedin-2-one; preparation procedure; pharmaceutical composition; combination; use in the treatment of a hyperlipidemic condition, atherosclerosis, Alzheimer's and cholesterol-associated tumors
Isoquinolin-1 (2h) -one derived compounds, selective inhibitors of poly (adp-ribose) polymerase parp-1 activity; process to prepare them; pharmaceutical composition; and its use to treat a disease mediated by the protein parp-1.
NON-NUCLEOSIDIC COMPOUNDS DERIVED FROM FENOXI-FENIL SUBSTITUTED, INHIBITORS OF THE HIV REVERSE TRANSCRIPT; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT PREVENT AN HIV INFECTION OR TO TREAT AIDS OR CRS.
COMPOUNDS DERIVED FROM MACROCICLES, INHIBITORS OF THE SERINE PROTEASE OF HEPATITIS C; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF HEPATITIS C.
Macrocyclic aminoindole derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c.
Compounds derived from heterocycle 1,4 substituted piperidine; intermediate compounds; pharmaceutical composition; Preparation process; and its use in the treatment of Alzheimer's and schizophrenia.